ArticleBMC neurology2025
Reverse blood flow treatment for aneurysmal subarachnoid hemorrhage due to interrupted aortic arch with aberrant right subclavian artery.
Article in BMC neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundInterrupted aortic arch (IAA) is a rare congenital defect involving complete discontinuity between the aortic arch and descending aorta. Aberrant right subclavian artery (ARSA) is a common variant, occasionally causing vascular complications. Intracranial aneurysm (IA) rupture leads to subarachnoid hemorrhage (SAH), a life-threatening event. The coexistence of IAA, ARSA, and IA is extremely rare and poses significant diagnostic and therapeutic challenges. CASE PRESENTATION: This report describes a young patient with type B IAA and ARSA, who also presented with multiple IA. The patient was admitted due to SAH. The extreme vessel angle of the right subclavian artery to the aorta and the reversal of blood flow in bilateral vertebral arteries made cerebral angiography and therapy difficult.
conclusionIn young patients with IA, underlying vascular anomalies affecting hemodynamics should be carefully evaluated. IAA with ARSA poses challenges for vascular access but does not preclude safe and effective endovascular treatment. Comprehensive assessment and individualized planning are essential for favorable long-term outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.